NAMI New Jersey, N Brunswick, NJ
NAMI Research Opportunity - Survey for adults with schizophrenia and/or their caregivers -
NAMI-A - Wikipedia
Redox-responsive Ru(III) complexes NAMI-A (15), KP1019 (16) KP1339 (17)... | Download Scientific Diagram
KP1019 - an overview | ScienceDirect Topics
NAMI-A - Wikipedia
Molecular structure of the antimetastatic compound NAMI-A. | Download Scientific Diagram
Anticancer Research – The Gasser Group
Taisa (Taya) Skubiak on LinkedIn: Schizophrenia clinical trial site staff interviews
Chemical structures of CDDP (a), NAMI-A (b), KP1019 (c), KP1339 (d) and... | Download Scientific Diagram
PDF) NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Chemical structure of NAMI-A, molecular weight 458.18 g/mol. | Download Scientific Diagram
Ru(III) complexes in clinical trials; NAMI-A and KP1019 | Download Scientific Diagram
Upcoming and Previous Events | Segal Trials
COVID-19 Vaccine::NAMI
KP1019 - an overview | ScienceDirect Topics
Patient Centricity | Segal Trials
Molecules | Free Full-Text | NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Molecules | Free Full-Text | NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Frontiers | Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
NAMI-A and KP1019/NKP1339 are ruthenium complexes that entered clinical... | Download Scientific Diagram
Ruthenium(III) compounds in clinical trials KP1019 and NAMI-A. 2,3 | Download Scientific Diagram
Molecules | Free Full-Text | NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
